Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 3/20 | 0.38 |
| ▸ | SLC6A11 | P48066 | 7/20 | 0.37 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25797603 | 0.90 | SLC6A11 (0.35) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL283757 | 0.86 | TYMP (0.44) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL13690826 | 0.86 | TYMP (0.44) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL23215181 | 0.86 | TYMP (0.44) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL9692839 | 0.80 | SLC6A11 (0.47) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL298850 | 0.79 | SLC6A11 (0.41) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL9694698 | 0.77 | SLC6A11 (0.41) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL14062478 | 0.76 | TYMP (0.36) | TYMPSLC6A11SLC6A1MEN1KMT2A | |
| SCHEMBL25797606 | 0.74 | — | — | |
| SCHEMBL14410561 | 0.72 | TYMP (0.39) | TYMPSLC6A11SLC6A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212204-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | THE SCRIPPS RESEARCH INSTITUTE | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212204-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | PNKP, POLL, RNGTT | TYMP 53/4885SLC6A11 4334/4885SLC6A1 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.